LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.05
EUR
-0.02
EUR
-1.13 %
15:16:52
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 2.43 USD | -0.09 USD | -3.50 % |
|---|
| Vortag | 2.52 USD | Datum | 23.04.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 81.00% | |
| 21shares Morpho ETP | CH1506167027 | 52.23% | |
| 21Shares Bittensor ETP | CH1495416971 | 5.82% | |
| 21shares Canton Network ETP | CH1503127917 | 0.82% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -3.16% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | -6.16% | |
| 21Shares Jupiter ETP | CH1480821383 | -9.20% | |
| 21Shares Dogecoin ETP | CH1431521033 | -20.46% | |
| 21Shares XDC Network ETP | CH1464217285 | -20.97% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -22.91% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 2.51% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 0.60% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | -8.82% | |
| 21Shares Artificial Superintelligence Alliance ETP | CH1480821375 | -21.03% | |
| 21Shares Render ETP | CH1396343266 | -27.76% | |
| 21Shares Bittensor ETP | CH1495416971 | -35.96% | |
| 21Shares Maple Finance ETP | CH1495416989 | -36.83% | |
| 21Shares Dogecoin ETP | CH1431521033 | -50.47% | |
| 21Shares XDC Network ETP | CH1464217285 | -50.94% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -52.68% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | 28.97% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | 27.92% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 23.02% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | 18.65% | |
| 21Shares Binance BNB ETP | CH0496454155 | 2.50% | |
| 21Shares Dogecoin ETP | CH1431521033 | -48.74% | |
| 21Shares Injective Staking ETP | CH1360612134 | -67.41% | |
| 21Shares Immutable ETP | CH1360612142 | -71.78% | |
| 21Shares Sui Staking ETP | CH1360612159 | -74.68% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 162.54% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 76.62% | |
| 21Shares Stellar ETP | CH1109575535 | 46.60% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 42.05% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 21.67% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 570’617.98 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 27.04.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 31.42 | |
| Performance 2 Jahre | 26.49 | |
| Performance 3 Jahre | 1.72 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
ETP Kategorievergleich
| Name | 1J Perf. | |
|---|---|---|
| Allianz Biotechnologie R EUR Fonds | 32.13 | |
| Allianz Biotechnologie P EUR Fonds | 32.28 | |
| DNB Fund - Biotechnology A EUR (Acc) Fonds | 32.60 | |
| L&G Pharma Breakthrough UCITS ETF | 33.31 | |
| L&G Pharma Breakthrough UCITS ETF | 33.31 |